STAT+: Sales of GSK’s RSV vaccine down dramatically from last year
STAT
OCTOBER 30, 2024
LONDON — GSK’s once booming vaccines business met new challenges in the third quarter, as the company lowered sales forecasts for vaccines for the year. It was clear that GSK’s vaccine division would see lower sales this quarter. recommendations for who should get the shot.
Let's personalize your content